These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 34318534

  • 1. A five-gene panel refines differential diagnosis of thyroid nodules.
    Lu SY, Chen YC, Zhu CF, Chen J, Zhou QY, Zhang MM, Zhang QY, Lu M, Yang L, Wu J, Zhao SX, Song HD, Ye XP.
    J Clin Lab Anal; 2021 Sep; 35(9):e23920. PubMed ID: 34318534
    [Abstract] [Full Text] [Related]

  • 2. Clinical Utility of BRAF, NRAS, and TERT Promoter Mutation in Preoperative Thyroid Fine-Needle Aspiration Biopsy: A Diagnostic Study From Dharmais Cancer Hospital.
    Perdana AB, Putri RI, Rachmawati R, Andinata B, Brahma B.
    Asian Pac J Cancer Prev; 2020 Nov 01; 21(11):3267-3277. PubMed ID: 33247684
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preoperative Role of RAS or BRAF K601E in the Guidance of Surgery for Indeterminate Thyroid Nodules.
    Ravella L, Lopez J, Descotes F, Giai J, Lapras V, Denier ML, Borson-Chazot F, Lifante JC, Decaussin-Petrucci M.
    World J Surg; 2020 Jul 01; 44(7):2264-2271. PubMed ID: 32227276
    [Abstract] [Full Text] [Related]

  • 5. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
    Beiša A, Kvietkauskas M, Beiša V, Stoškus M, Ostanevičiūtė E, Jasiūnas E, Griškevičius L, Šeinin D, Šileikytė A, Strupas K.
    Exp Clin Endocrinol Diabetes; 2019 Apr 01; 127(4):247-254. PubMed ID: 29566402
    [Abstract] [Full Text] [Related]

  • 6. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
    An JH, Song KH, Kim SK, Park KS, Yoo YB, Yang JH, Hwang TS, Kim DL.
    Clin Endocrinol (Oxf); 2015 May 01; 82(5):760-6. PubMed ID: 25109485
    [Abstract] [Full Text] [Related]

  • 7. The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?
    Lei L, Hong Qing S, Wei L, Ma Mo Yang F, Xiao Xiang Y.
    Am Surg; 2024 Dec 01; 90(12):3209-3215. PubMed ID: 39047144
    [Abstract] [Full Text] [Related]

  • 8. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.
    Qi W, Shi C, Zhang P, Feng L, Wang J, Chen D.
    Pathol Res Pract; 2020 Aug 01; 216(8):153037. PubMed ID: 32703500
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.
    Lan Z, Yang F, Zhang J, Lan Y, Li H, He R.
    Acta Cytol; 2023 Aug 01; 67(6):629-638. PubMed ID: 37708867
    [Abstract] [Full Text] [Related]

  • 11. Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.
    Liu S, Gao A, Zhang B, Zhang Z, Zhao Y, Chen P, Ji M, Hou P, Shi B.
    Exp Mol Pathol; 2014 Oct 01; 97(2):292-7. PubMed ID: 25111330
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis.
    Park SJ, Sun JY, Hong K, Kwak JY, Kim EK, Chung WY, Choi JR.
    Clin Chem Lab Med; 2013 Aug 01; 51(8):1673-80. PubMed ID: 23585181
    [Abstract] [Full Text] [Related]

  • 14. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
    Witt RL.
    Del Med J; 2016 Dec 01; 88(12):366-372. PubMed ID: 29461717
    [Abstract] [Full Text] [Related]

  • 15. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC.
    J Clin Endocrinol Metab; 2012 Jul 01; 97(7):2354-61. PubMed ID: 22535974
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.
    Diagn Cytopathol; 2015 Oct 01; 43(10):786-90. PubMed ID: 26152656
    [Abstract] [Full Text] [Related]

  • 18. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.
    Clin Endocrinol (Oxf); 2006 Nov 01; 65(5):660-6. PubMed ID: 17054470
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.